Top 20 Syntaxin investors
The most complete profiles first. Showing 20 of 20.
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Marian NakadaVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Vijay MurthyVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Asish Xavier
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Jeanne Bolger
Venture Capital, Corporate Venture Capital, Investor · United Kingdom
Series AHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Prosensa15
- Nouscom15
- Effector Therapeutics11
- Dicerna Pharmaceuticals11
- CRISPR Therapeutics11
- Gynesonics10
- Cytos10
- Kspine10
- Personalis10
- Valeritas10
- Avila Therapeutics10
Frequently asked questions
How many Syntaxin investors are on Angel Roster?
Angel Roster lists 20 Syntaxin investors. 7 of them (35%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (9) and Corporate Venture Capital Firms (5). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Syntaxin investors invest in?
Among those that list a stage, the most common are Series B (9), Seed (2) and Series A (1).
Where are Syntaxin investors based?
Most are based in the United Kingdom (8), the United States (8) and the Netherlands (3).
Which companies have Syntaxin investors backed?
The most-backed portfolio companies among them are Prosensa (15), Nouscom (15), Effector Therapeutics (11), Dicerna Pharmaceuticals (11) and CRISPR Therapeutics (11).
How do I contact Syntaxin investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.